Previous studies have confirmed that TAMs not only promote tumor initiation but also serve as central drivers of immunosuppressive TIME by expressing cell surface receptors, secreting cytokines, chemokines, and enzymes that regulate the recruitment and function of multiple immune cell subtypes (65). This evidence concerns the gene CD177 and neoplasm.